Presepsin (soluble CD14 subtype) Is Available in Febrile Neutropenic Patients with Hematological Malignancy As Diagnosis and Assesment Biomarker of Infections

被引：0
|
作者：
Oyake, Tatsuo [1 ]
Masuda, Takayuki [2 ]
Sugawara, Norifumi [1 ]
Asahi, Maki [1 ]
Suzuki, Yuzo [1 ]
Okano, Yoshiaki [1 ]
Fujishima, Yukiteru [1 ]
Aoki, Yusei [1 ]
Kowata, Shugo [1 ]
Ito, Shigeki [3 ]
Ishida, Yoji [1 ]
机构：
[1] Iwate Med Univ, Sch Med, Dept Internal Med, Hematol Oncol, Morioka, Iwate 020, Japan
[2] Iwate Med Univ, Iwate Prefectural Adv Crit Care & Emergency Ctr, Dept Crit Care & Emergency, Morioka, Iwate 020, Japan
[3] Iwate Med Univ, Sch Med, Div Clin Oncol, Morioka, Iwate 020, Japan
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients
    Klouche, Kada
    Cristol, Jean Paul
    Devin, Julie
    Gilles, Vincent
    Kuster, Nils
    Larcher, Romaric
    Amigues, Laurent
    Corne, Philippe
    Jonquet, Olivier
    Dupuy, Anne Marie
    ANNALS OF INTENSIVE CARE, 2016, 6
  • [22] Presepsin (soluble CD14 subtype) as a risk factor for the development of infectious and inflammatory complications in operated colorectal cancer patients
    Shakeyev, Kayrat
    Turgunov, Yermek
    Ogizbayeva, Alina
    Avdiyenko, Olga
    Mugazov, Miras
    Grigolashvili, Sofiko
    Azizov, Ilya
    ANNALS OF COLOPROCTOLOGY, 2022, 38 (06) : 442 - 448
  • [23] Evaluation of a soluble CD14 subtype in patients with surgical sepsis
    Y Fukui
    Critical Care, 16 (Suppl 3):
  • [24] Presepsin (soluble CD14 subtype) levels in cirrhotic patients with bacterial infections and/or portal hypertension related bleeding presented with or without acute kidney injury
    Elefsiniotis, I. S.
    Tsakiris, S.
    Barla, G.
    Tasovasili, A.
    Stathopoulou, I.
    Tampouratzi, K.
    Evangelidou, E.
    Vrachatis, D.
    Mavrogiannis, C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S375 - S375
  • [25] Presepsin (soluble CD14 subtype) as a new sepsis marker: first results of the diagnostic and prognostic validity
    Spanuth, E.
    Ebelt, H.
    Ivandic, B.
    Werdan, K.
    INFECTION, 2011, 39 : S113 - S113
  • [26] Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates
    Pugni, Lorenza
    Pietrasanta, Carlo
    Milani, Silvano
    Vener, Claudia
    Ronchi, Andrea
    Falbo, Mariella
    Arghittu, Milena
    Mosca, Fabio
    PLOS ONE, 2015, 10 (12):
  • [27] SOLUBLE CD14 (PRESEPSIN) AS A POTENTIAL BIOMARKER TO DISCRIMINATE INFECTION VS. ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Posso-Osorio, I.
    Echeverry, A.
    Aguirre-Valencia, D.
    Castano, G.
    Tobon, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1225 - 1225
  • [28] Presepsin, Soluble CD14 Subtype, is a Novel Marker of Six-Month Mortality in Patients Hospitalized to Coronary Care Units
    Nishimura, Hideto
    Ishii, Junnichi
    Takahashi, Hiroshi
    Kawai, Hideki
    Muramatsu, Takashi
    Harada, Masahide
    Motoyama, Sadako
    Matsui, Shigeru
    Naruse, Hiroyuki
    Watanabe, Eiichi
    Hayashi, Mutsuharu
    Izawa, Hideo
    Ozaki, Yukio
    CIRCULATION, 2017, 136
  • [29] Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units
    Ishii, J.
    Takahashi, H.
    Nishimura, H.
    Fujiwara, W.
    Ohta, M.
    Kawai, H.
    Muramatsu, T.
    Harada, M.
    Yamada, A.
    Naruse, H.
    Motoyama, S.
    Watanabe, E.
    Izawa, H.
    Ozaki, Y.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1838 - 1838
  • [30] Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department
    de Guadiana Romualdo, Luis Garcia
    Esteban Torrella, Patricia
    Viqueira Gonzalez, Monserrat
    Jimenez Sanchez, Roberto
    Hernando Holgado, Ana
    Ortin Freire, Alejandro
    Rebollo Acebes, Sergio
    Albaladejo Oton, Maria Dolores
    CLINICAL BIOCHEMISTRY, 2014, 47 (7-8) : 505 - 508
12345